SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria Francesca Donato, Sara Monico, Federica Malinverno, Alessio Aghemo, Marco Maggioni, Paolo Reggiani, Massimo Colombo, Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?, Liver International, 2014, 34, 9
  2. 2
    E. J. Gane, K. Agarwal, Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”, American Journal of Transplantation, 2014, 14, 5
  3. 3
    Taizo Hibi, Seigo Nishida, Junichiro Sageshima, David M. Levi, Phillip Ruiz, David Roth, Paul Martin, Koji Okabayashi, George W. Burke, Gaetano Ciancio, Andreas G. Tzakis, Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C, Transplant International, 2014, 27, 6
  4. 4
    H. Konishi, T. Motomura, Y. Matsumoto, N. Harimoto, T. Ikegami, T. Yoshizumi, Y. Soejima, K. Shirabe, T. Fukuhara, Y. Maehara, Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant, Journal of Viral Hepatitis, 2014, 21, 6
  5. 5
    G. Crespo, S. Lens, M. Gambato, J. A. Carrión, Z. Mariño, M.-C. Londoño, R. Miquel, J. Bosch, M. Navasa, X. Forns, Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C, American Journal of Transplantation, 2014, 14, 2
  6. 6
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo, Susumu Eguchi, Toshiyoshi Fujiwara, Hideki Ohdan, Hiroaki Nagano, Akinobu Taketomi, Yuko Kitagawa, Mitsuo Shimada, Yonson Ku, Katsuhiko Yanaga, Ken Shirabe, Toru Ikegami, Masashi Mizokami, Masahiro Takeuchi, Yoshihiko Maehara, Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey, Transplant International, 2014, 27, 8
  7. 7
    A.J. Thompson, P. Clark, A. Aghemo, Handbook of Pharmacogenomics and Stratified Medicine, 2014,

    CrossRef

  8. 8
    Gonzalo Crespo, José A. Carrión, Mairene Coto-Llerena, Zoe Mariño, Sabela Lens, Sofía Pérez-del-Pulgar, Montserrat García-Retortillo, Rosa Miquel, Jaime Bosch, Miquel Navasa, Xavier Forns, Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation, Journal of Gastroenterology, 2013, 48, 6, 762

    CrossRef

  9. 9
    Marina Berenguer, Bruno Roche, Victoria Aguilera, Jean-Charles Duclos-Vallée, Laia Navarro, Angel Rubín, Jose-Antonio Pons, Manuel de la Mata, Martín Prieto, Didier Samuel, Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach, Liver Transplantation, 2013, 19, 1
  10. 10
    Pratima Sharma, Amy Hosmer, Henry Appelman, Barbara McKenna, Mohammad S. Jafri, Patricia Sullivan, Robert J. Fontana, Anna S. Lok, Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival, Hepatology International, 2013, 7, 4, 990

    CrossRef

  11. 11
    Andres Duarte-Rojo, Vikram Budhraja, Bart J. Veldt, David D. Goldstein, Kymberly D. Watt, Julie K. Heimbach, John G. McHutchison, Hans L. Tillman, John J. Poterucha, Michael R. Charlton, Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: A case-control study and literature review, Liver Transplantation, 2013, 19, 12
  12. 12
    Ivo Graziadei, Lebertransplantation, Wiener klinische Wochenschrift Education, 2013, 8, 2, 43

    CrossRef

  13. 13
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  14. You have free access to this content14
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  15. 15
    Maria-Carlota Londoño, Gonzalo Crespo, Xavier Forns, Pretransplant and posttransplant treatment of hepatitis C virus infection with protease inhibitors, Current Opinion in Organ Transplantation, 2013, 18, 3, 271

    CrossRef

  16. 16
    Marina Berenguer, Detlef Schuppan, Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment, Journal of Hepatology, 2013, 58, 5, 1028

    CrossRef

  17. 17
    R. J. Fontana, E. A. Hughes, M. Bifano, H. Appelman, D. Dimitrova, R. Hindes, W. T. Symonds, Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C, American Journal of Transplantation, 2013, 13, 6
  18. 18
    YoungRok Choi, Kwang-Woong Lee, The Management of HCV Recurrence after Liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 2, 37

    CrossRef

  19. 19
    Tomohiro Tanaka, Nazia Selzner, George Therapondos, Eberhard L. Renner, Leslie B. Lilly, Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients, Transplant International, 2013, 26, 1
  20. 20
    Robert J. Fontana, Eric A. Hughes, Henry Appelman, Robert Hindes, Dessislava Dimitrova, Marc Bifano, Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation, Liver Transplantation, 2012, 18, 9
  21. 21
    Marina Berenguer, Victoria Aguilera, Angel Rubín, Cecilia Ortíz, Martina Jimenez, Martín Prieto, Comparison of two non-contemporaneous HCV-liver transplant cohorts: Strategies to improve the efficacy of antiviral therapy, Journal of Hepatology, 2012, 56, 6, 1310

    CrossRef

  22. 22
    Masashi Mizokami, Discovery of critical host factor, IL-28B, associated with response to hepatitis C virus treatment, Journal of Gastroenterology and Hepatology, 2012, 27, 3
  23. 23
    Julieta Trinks, Adrián Gadano, Pablo Argibay, Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome, Epidemiology Research International, 2012, 2012, 1

    CrossRef

  24. 24
    Anthony D. Martinez, Robert G. Gish, HCV In At Risk Populations: Who Can be Treated and How?, Current Hepatitis Reports, 2012, 11, 1, 1

    CrossRef

  25. 25
    David R. Nelson, Donald M. Jensen, Mark S. Sulkowski, Greg Everson, Michael W. Fried, Stuart C. Gordon, Ira Jacobson, Nancy S. Reau, Kenneth Sherman, Nora Terrault, David Thomas, Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy, Hepatitis Research and Treatment, 2012, 2012, 1

    CrossRef

  26. 26
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  27. 27
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  28. 28
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  29. 29
    Gonzalo Crespo, Zoe Mariño, Miquel Navasa, Xavier Forns, Viral Hepatitis in Liver Transplantation, Gastroenterology, 2012, 142, 6, 1373

    CrossRef

  30. 30
    Michela Giusto, Maria Rodriguez, Laia Navarro, Angel Rubin, Victoria Aguilera, Fernando San-Juan, Cecilia Ortiz, Rafael López-Andujar, Martín Prieto, Marina Berenguer, Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin, Liver Transplantation, 2011, 17, 11
  31. 31
    T. Casanovas, A. Argudo, M.C. Peña-Cala, Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports, Transplantation Proceedings, 2011, 43, 6, 2233

    CrossRef

  32. 32
    Maria Rendina, Stefano Fagiuoli, Patrizia Burra, Nicola Maurizio Castellaneta, Marianna Zappimbulso, Antonio Castellaneta, Roberto Bringiotti, Salvatore Fiabio Rizzi, Annamaria Squicciarino, Luigi Lupo, Alfredo Di Leo, Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome, Digestive and Liver Disease Supplements, 2011, 5, 1, 30

    CrossRef

  33. 33
    Michael R. Charlton, Alexander Thompson, Bart J. Veldt, Kym Watt, Hans Tillmann, John J. Poterucha, Julie K. Heimbach, David Goldstein, John McHutchison, Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection, Hepatology, 2011, 53, 1
  34. 34
    J. A. Wertheim, H. Petrowsky, S. Saab, J. W. Kupiec-Weglinski, R. W. Busuttil, Major Challenges Limiting Liver Transplantation in the United States, American Journal of Transplantation, 2011, 11, 9
  35. 35
    Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton, PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus, Liver Transplantation, 2011, 17, 5
  36. 36
    Jacinta A. Holmes, Paul V. Desmond, Alexander J. Thompson, Redefining Baseline Demographics: The Role of Genetic Testing in Hepatitis C Virus Infection, Clinics in Liver Disease, 2011, 15, 3, 497

    CrossRef

  37. 37
    Michael Charlton, Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents — A potentially lethal cocktail, Hepatology, 2011, 54, 1
  38. 38
    Ashwani K. Singal, Amanpal Singh, Sathya Jaganmohan, Praveen Guturu, Rajasekhara Mummadi, Yong–Fang Kuo, Gagan K. Sood, Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis, Clinical Gastroenterology and Hepatology, 2010, 8, 2, 192

    CrossRef

  39. 39
    Sven C. Schmidt, Marcus Bahra, Sandra Bayraktar, Thomas Berg, Maximilian Schmeding, Johann Pratschke, Peter Neuhaus, Ulf Neumann, Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon, Digestive Diseases and Sciences, 2010, 55, 7, 2063

    CrossRef

  40. 40
    Bruno Roche, Didier Samuel, Are viral or host factors predictive of response to interferon–ribavirin in transplant patients with hepatitis C?, Journal of Hepatology, 2010, 52, 5, 630

    CrossRef

  41. 41
    Ayse Aytaman, Marina Kaufman, Norah A Terrault, Management of posttransplant hepatitis C infection, Current Opinion in Organ Transplantation, 2010, 15, 3, 301

    CrossRef

  42. 42
    Takasuke Fukuhara, Akinobu Taketomi, Shinji Okano, Toru Ikegami, Yuji Soejima, Ken Shirabe, Yoshihiko Maehara, Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation, Journal of Hepatology, 2010, 52, 5, 672

    CrossRef

  43. 43
    Takasuke Fukuhara, Akinobu Taketomi, Takashi Motomura, Shinji Okano, Akinori Ninomiya, Takayuki Abe, Hideaki Uchiyama, Yuji Soejima, Ken Shirabe, Yoshiharu Matsuura, Yoshihiko Maehara, Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C, Gastroenterology, 2010, 139, 5, 1577

    CrossRef

  44. 44
    K. Watt, B. Veldt, M. Charlton, A Practical Guide to the Management of HCV Infection Following Liver Transplantation, American Journal of Transplantation, 2009, 9, 8
  45. 45
    Shahid M. Malik, Michael E. deVera, Paulo Fontes, Obaid Shaikh, Eizaburo Sasatomi, Jawad Ahmad, Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis, Liver Transplantation, 2009, 15, 12
  46. 46
    Kimberly A Brown, Mary Ann Huang, Marwan Kazimi, Dilip Moonka, Liver Transplantation,
  47. 47
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  48. 48
    Brett E Fortune, Hugo R Rosen, James R Burton, Management of HCV Infection and Liver Transplantation,
  49. 49
    Kymberly D. S. Watt, Marie A. Laryea, Recurrent Disease Following Liver Transplantation,